San Francisco, CA, United States of America

Napoleane Ferrara


Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:

goldMedal1 out of 832,912 
Other
 patents

Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Napoleane Ferrara in Pharmaceutical Chemistry

Introduction

Napoleane Ferrara is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic applications.

Latest Patents

Ferrara holds a patent for "Acylguanidine derivatives as inhibitors of bone resorption and as vitronectin receptor antagonists." This invention relates to acylguanidine derivatives of a specific formula, which are valuable pharmaceutical active ingredients. The compounds are designed to act as vitronectin receptor antagonists and inhibitors of bone resorption by osteoclasts. They are particularly suitable for the therapy or prophylaxis of diseases such as osteoporosis, which are caused by excessive bone resorption. The patent also covers processes for the preparation of these compounds and their use in pharmaceutical preparations.

Career Highlights

Throughout his career, Ferrara has focused on innovative solutions in the pharmaceutical industry. His work has led to advancements in the treatment of bone-related diseases, showcasing his commitment to improving health outcomes through scientific research.

Collaborations

Ferrara has collaborated with notable professionals in his field, including Anuschirwan Peyman and Jochen Knolle. These collaborations have likely contributed to the success and development of his innovative pharmaceutical compounds.

Conclusion

Napoleane Ferrara's contributions to pharmaceutical chemistry, particularly through his patent on acylguanidine derivatives, highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in the treatment of bone resorption-related diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…